Latest News in Cancer
Stay updated with the most recent articles and resources.
Main Topics
How China is leading the development of CAR T-Cell therapy?
The number of CAR-T therapy trials in China surpassed those in the United States by 2018 as a result of this thriving ecosystem. As of...
Cargo, a cancer drug startup, raises $200 million to combat CAR-T relapse
March 2023: Several types of lymphoma, as well as certain leukaemias and multiple myeloma, can now be effectively treated with CAR-T therapy. Recent studies have...
New CAR T-Cell therapy drug in lupus renaissance
Feb 2024: Several new drugs and promising therapies, such as chimeric antigen receptor T-cell therapy, have ushered in a “renaissance” for lupus, according to a...
Perspectives on cancer experiences with oncologist Dr. Willie Goffney
Feb 2023: Check out this tweet from the American Cancer Society that shares a conversation with Dr. Willie Goffney about her perspective on cancer. A...
Enhertu has been approved in China for patients with HER2-positive metastatic breast cancer
Feb 2023: Enhertu (trastuzumab deruxtecan) from AstraZeneca and Daiichi Sankyo has been approved as a monotherapy for the treatment of adult patients with unresectable or...
Actor Hamsa Nandini Provides an Update One Year After Breast Cancer Treatment
Feb 2023: Hamsa Nandini, who was diagnosed with Grade III Invasive Carcinoma (Breast Cancer) in 2021, has updated her Instagram followers on her health status....
Global cost of cancer projected to exceed $25 Trillion by 2050
Feb 2023: According to data published in JAMA Oncology, the global economic cost of cancer is projected to reach $25,2 trillion in international dollars (INT)...
Can advanced-stage cancer be cured? Check the latest developments
Check out how the overall landscape of cancer treatment has changed in the last few years. Even advanced-stage cancers can be effectively treated with the...
Kite completes acquisition of Tmunity
Press Release Feb 2023: – Kite, a Gilead Company (NASDAQ: GILD), today announced the completion of the previously announced transaction to acquire Tmunity Therapeutics (Tmunity), a clinical-stage,...
High CR rates are overcome by CD22-directed CAR T-Cell therapy against CD19 relapse in LBCL
In February 2023, a phase 1 trial at a single institution found that it was safe and possible for people with heavily pretreated large B-cell...
CAR T-cell treatment provides significant remission rates in clinical trials
Feb 2023: In a Phase III study, a CAR T-cell therapy more than tripled progression-free survival compared with standard care for triple-class exposed multiple myeloma....
Novel treatment target for lymphoma patients who relapse after CAR-T therapy
Feb 2023: The results of the trial demonstrated that a novel chimeric antigen receptor T-cell therapy elicited a response in adults with advanced large B-cell...
Need help? Our team is ready to assist you.
We wish a speedy recovery for your loved ones.